Suppr超能文献

[不同化学结构的抗抑郁药对大鼠大脑皮质切片中去甲肾上腺素摄取和释放的影响]

[Effect of antidepressants with different chemical structures on the uptake and release of norepinephrine in sections of the rat cerebral cortex].

作者信息

Dolzhenko A T

出版信息

Biull Eksp Biol Med. 1982 Mar;93(3):29-31.

PMID:6284275
Abstract

Experiments with slices of the rat cortex were made to study the interaction between the ability of the antidepressants to inhibit the reverse uptake of 14C-noradrenaline and to inhibit its presynaptic release. The antidepressants studied are distributed into 3 groups according to the ratio of effective concentrations that block the uptake and enhance the release of 14C-noradrenaline from the slices. The first group includes the antidepressants (melipramine, chlorimipramine, Lu 5-003, Lu 3-010, S-394, pyrazidol) that have a ratio close to I and in whose mechanism of aminopotentiating action the main component is unlikely to be distinguished. The second group with a ratio less than I is represented by the substances (nortryptyline, desipramine) whose mechanism of the aminopotentiating action is determined by the inhibitory effect on the neurotransmitter reverse uptake. As to the 3d group antidepressants (thyroliberin, iprindol, noveril, C-356, C-395, amitryptyline), of great importance is their effect on the presynaptic neurotransmitter release from the terminals of the axons of noradrenergic neurons.

摘要

进行了大鼠皮质切片实验,以研究抗抑郁药抑制14C - 去甲肾上腺素逆向摄取的能力与其抑制其突触前释放之间的相互作用。根据阻断摄取并增强切片中14C - 去甲肾上腺素释放的有效浓度之比,将所研究的抗抑郁药分为3组。第一组包括抗抑郁药(丙咪嗪、氯米帕明、Lu 5 - 003、Lu 3 - 010、S - 394、吡唑朵),其比例接近1,且在其氨基增强作用机制中,主要成分不太可能被区分出来。第二组比例小于1,以物质(去甲替林、地昔帕明)为代表,其氨基增强作用机制由对神经递质逆向摄取的抑制作用决定。至于第三组抗抑郁药(促甲状腺素释放激素、茚满丙二胺、诺米芬辛、C - 356、C - 395、阿米替林),它们对去甲肾上腺素能神经元轴突终末突触前神经递质释放的影响非常重要。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验